Chinook Therapeutics Inc (KDNY) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chinook Therapeutics Inc   (NASDAQ: KDNY)


Chinook Therapeutics Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Chinook Therapeutics Inc 's ROA in the second quarter of 2023?
Chinook Therapeutics Inc recorded a cumulative net loss of $-246 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -48.9%.

However, within the Healthcare sector 651 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2023 from 4474 to 4491.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -18.78 % 62.25 % 3.51 % 65.04 % 54.79 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -246 -216 -188 -118 -92
Return On Assets (TTM) -48.9 % -40.96 % -39.1 % -24.74 % -21.87 %
KDNY's Total Ranking # 4491 # 4474 # 5023 # 4226 # 4293
Total Assets (TTM) in million 446 497 526 540 549
Seq. Total Assets Change -10.31 % -5.46 % -2.68 % -1.57 % 79.17 %
Seq. Net Income Change - - - - -

KDNY's 5 Years Annual ROA >> Back to KDNY Management Effectiveness >> Compare KDNY ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 279
Sector # 652
Overall # 4401

Return On Assets Statistics
High Average Low
-4.87 %
-24.15 %
-44.72 %
(Jun 30 2016)   (Jun 30 2023)





Financial Statements
Chinook Therapeutics Inc 's Assets $ 446 million KDNY's Balance sheet
Chinook Therapeutics Inc 's Income $ -67 million Quarterly KDNY's Income Statement
KDNY's Income by Division See KDNY's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change 3.51 % 35.78 % 38.74 % -24.45 % -19.79 %
Total Assets in million 526 508 374 270 357
Y / Y Net Income Change - - - - -
Net Income in million -188 -103 -82 -82 -95
Annual Return On Assets -35.72 % -20.26 % -21.81 % -30.54 % -26.71 %

KDNY's 5 Years Annual ROA >> Back to KDNY Management Effectiveness >> Compare KDNY ROA to its Competitors



More Return On Assets Ratios
KDNY's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KDNY's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KDNY's Competitors
Subscribers only: Roa for Chinook Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for KDNY's Customers

You may also want to know
KDNY's Roi KDNY's Inventory Turnover Ratio KDNY's Growth Rates KDNY's Dividend Comparisons
KDNY's Profitability Ratios KDNY's Asset Turnover Ratio KDNY's Dividend Growth
KDNY's Roe KDNY's Valuation Ratios KDNY's Financial Strength Ratios KDNY's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.